Free Shipping on purchases over €100

Rilastil Xerolact Podos Moisturising Keratolytic Lipogel 100 ml

Rilastil Xerolact Podos Lipogel is a cosmetic that has the ability to moisturise the skin of the feet. Its recurrent use helps to minimise the feeling of tightness and itching that normally occurs in dry and cracked skin.

SKU: 188030
-24%
20% discount.
11.30
€14.84
€11.30
/100ml

Pharmaceutical Care

Safe medication sales

Secure shipping

INFO AND TECHNICAL SPECIFICATIONS

Rilastil Xerolact Podos Lipogel is a skin care cosmetic specially formulated for the area of the foot that comes into contact with the ground when walking. It contains a large number of components that provide the following benefits:

  • Firstly, sodium lactate is the active ingredient responsible for promoting natural moisturisation. It contains a large amount of proteins, urea, lactic acid, sugar and also potassium and magnesium ions. All of these are important so that the skin does not gradually lose moisture. In addition to this, it has the ability to regulate the pH of the area and has a keratolytic effect. This means that it helps dead cells to slough off the horny layer.
  • It has a texture that is quickly absorbed and does not leave an uncomfortable sensation.
  • Another important component of this product is glycerin, which helps to moisturise. Its action concentrates especially on trapping water molecules present in the air. As a result, the skin can absorb them and gradually hydrate itself.
  • Allantoin and panthenol are responsible for softening the skin and re-epithelialising (aiding the healing process).
  • Nylon 6 ensures that the structure of the foot is not too smooth. The benefit of this is that you will have a better adhesion on the surfaces.
Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.